|
HS Code |
659274 |
| Chemical Name | 4-Bromo-3-Iodo-7-Azaindole |
| Molecular Formula | C7H4BrIN2 |
| Molecular Weight | 338.93 g/mol |
| Cas Number | 887593-46-0 |
| Appearance | Off-white to pale yellow solid |
| Purity | Usually ≥ 97% (commercial supply) |
| Smiles | Brc1cc2c(nccc2n1)I |
| Inchi | InChI=1S/C7H4BrIN2/c8-4-3-5-6(9)1-2-10-7(5)11-4/h1-3H,(H,10,11) |
| Synonyms | 4-Bromo-3-iodo-1H-pyrrolo[2,3-b]pyridine |
| Storage Conditions | Store at 2-8°C, protected from light and moisture |
As an accredited 4-Bromo-3-Iodo-7-Azaindole factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.
| Packing | |
| Shipping | |
| Storage |
Competitive 4-Bromo-3-Iodo-7-Azaindole prices that fit your budget—flexible terms and customized quotes for every order.
For samples, pricing, or more information, please call us at +8615371019725 or mail to admin@sinochem-nanjing.com.
We will respond to you as soon as possible.
Tel: +8615371019725
Email: admin@sinochem-nanjing.com
Flexible payment, competitive price, premium service - Inquire now!
Chemists spend hours in the lab troubleshooting reactions and searching for new routes to build useful molecules. In a world that asks for more precision and efficiency from research and development, 4-Bromo-3-Iodo-7-Azaindole brings options that just didn’t exist a few decades ago. Featuring a bromine and iodine atom in positions three and four on the versatile 7-azaindole structure, this compound proves itself over and over as a flexible intermediate for those who want to create new biological probes, pharmaceutical leads, and materials that demand pinpoint substituent installation. My own work in academia exposed how much time and effort go into fine-tuning the reactivity of heterocycles, and this molecule stands out by making certain transformations much more approachable.
With 4-Bromo-3-Iodo-7-Azaindole, chemists aren’t just limited to one type of reaction. The structure includes both bromine and iodine atoms, offering multiple distinct points for further functionalization using palladium-catalyzed cross-coupling reactions, among other strategies. I have watched colleagues rapidly build libraries of analogs using this approach—one step instead of many, one precursor instead of dozens. Because of its dual halide placement, synthetic chemists pick and choose which halogen to react first, letting them control the order of introduction for various substituents. This flexibility taps into a modern concept: accelerating the journey from thought to molecule, not wasting months on hard-to-control ring substitutions.
In real-life research, small changes to a molecular scaffold can lead to major shifts in biological activity or material properties. The 7-azaindole ring already has a legacy in drug discovery, showing up in kinase inhibitors and CNS-active agents. The unique patterning of bromine and iodine on this ring doesn’t just help with synthetic flexibility; it also gives chemists a vantage point to systematically explore how each change influences target binding or optical properties. Commercially available 4-Bromo-3-Iodo-7-Azaindole often arrives as a pale powder, stable under standard benchtop conditions. Structural confirmation by NMR, MS, and x-ray crystallography matches expectations for the substituted azaindole core, giving researchers confidence from the start that their starting material is well-characterized.
My own frustration with inefficient routes to substituted heterocycles showed me that a smarter starting material can save weeks or even months. With 4-Bromo-3-Iodo-7-Azaindole, chemists commonly pursue Suzuki-Miyaura or Buchwald-Hartwig couplings, choosing selective activation of either the bromine or the iodine atom under appropriate reaction conditions. By targeting the more reactive iodine first, then returning to modify the bromine, it’s possible to incorporate two entirely different substituents on the same scaffold in a predictable order. The high reactivity of the iodo position brings benefits in cross-coupling, cutting down on catalyst loading, temperature, and sometimes even reaction time, which matters when running screens or preparing multi-gram batches.
In medicinal chemistry, discovering new kinase or protein inhibitors often involves preparing a large pool of related compounds. This molecule gives quick access to a breadth of derivatives, supporting structure-activity relationship studies with fewer steps compared to making each analog separately. Chemists pushing into unexplored chemical space often mention how adaptable the 7-azaindole ring is, especially with two halides waiting for further elaboration.
Halogenated azaindoles are no strangers to synthetic chemistry, but the placement and kind of halogen atoms make a tangible difference. Take, for example, 3-bromo-7-azaindole or 4-iodo-7-azaindole. Each of those restricts functionalization to single-site modifications or limits the degree of orthogonal reactivity available to the chemist. My experience comparing these options made clear that having both bromine and iodine present on the same ring opens the door to regioselective transformations that aren't possible using only one halogen. This dual handle lets researchers introduce two separately optimized fragments—ideal for tuning both the potency and selectivity of drug candidates or customizing optoelectronic properties in new materials.
One subtlety is the difference in electronic character brought about by the aza group at the 7-position. Research has shown that azaindole derivatives can interact differently with biological targets and catalytic systems compared to their indole cousins, thanks to altered hydrogen bonding and electron density across the ring. In practical terms, if you aim to build out a pharmacophore with novel activity—or solve an old problem using a fresh core—using 4-Bromo-3-Iodo-7-Azaindole provides both the scaffold and the reliable handles for systematic modifications. It also sidesteps some of the unpredictable issues seen with monohalogenated or non-aza systems in late-stage diversification.
Trying to keep up with the pace of innovation in pharmaceutical or material science research, chemists are always looking for ways to speed up analog synthesis and probe design. My own time in a startup lab taught me there’s rarely enough bandwidth for complex multi-step preparations, so the practical impact of a versatile intermediate like 4-Bromo-3-Iodo-7-Azaindole becomes obvious. It helps labs stretch tight budgets, meet tight deadlines, and focus on discovery, not on preparative headaches.
There’s also an environmental angle to consider. Each extra purification or column chromatography run contributes to solvent use and chemical waste. By building complexity onto a single, well-designed intermediate, total process mass intensity drops. More straightforward functionalization also trims the number of chromatographic separations, making chemistry easier for everyone from students to seasoned professionals.
Stepping away from drug discovery for a moment, I’ve noticed interest growing in heterocycles for new materials and devices. The azaindole core, especially with carefully placed halides like in 4-Bromo-3-Iodo-7-Azaindole, gives material chemists the playground they need for building custom electronic and optoelectronic devices. Substituted azaindoles can influence charge carrier mobility, tune emission wavelengths, or create unique polymer backbones. Academic papers over the past five years highlight how such scaffolds end up in OLEDs, OFETs, and other devices at the cutting edge of organic electronics.
On the surface, these functional materials might seem unrelated to anything happening in a medicinal chemistry lab. But the synthetic strategies cross over—robust, selective couplings and the need for structural variety drive innovation no matter the downstream application. Anyone who has worked through the struggle of building out such an array will value how two reactive sites in one molecule can streamline the whole workflow.
Working with halogenated heterocycles takes some know-how, even if 4-Bromo-3-Iodo-7-Azaindole itself generally poses fewer surprises than more reactive brominated aromatics or polyhalogenated benzenes. I always wear gloves and use good ventilation, as with any finely powdered material, since inhalation risks and minor skin irritation shouldn’t be overlooked. Institutions usually have guidelines in place for handling organic bromides and iodides, which serve well when introducing new intermediates to the bench. Waste management matters too—halogenated byproducts often call for targeted disposal due to potential environmental impact.
Even as synthesis pushes into faster, more modular methods, it remains crucial for labs to train new scientists not just in the “how” of advanced coupling chemistry, but also in the responsible handling and disposal of halogenated waste streams. As more intermediates like 4-Bromo-3-Iodo-7-Azaindole find their way into daily use, I expect stronger emphasis both on safety culture and on improvements in green chemistry across the field.
There’s a real craft to getting the most out of 4-Bromo-3-Iodo-7-Azaindole. Seasoned chemists experiment with reaction conditions to target either the bromine or the iodine position for the first coupling—temperature, base, solvent, and catalyst all play a part. Working with skilled collaborators, some prefer to use a bulky ligand to encourage selectivity, while others adjust the order of addition and purification depending on both the scale and the downstream application. Such choices aren’t just academic; they impact yield, time, and overall project success. From my own bench chemistry, I can tell the difference between working with intermediates that only “sort of work” versus those that offer reproducible, high-conversion outcomes like this one tends to do.
After installing the first group—say, a biaryl for testing as a receptor ligand—chemists can fine-tune the conditions to append a different group at the remaining halide. The order matters because the iodine frequently reacts more rapidly, while the bromine offers higher thermal stability for certain transformations. Some groups even report tandem, one-pot procedures starting from this molecule, further simplifying workflows for labs that lack the time or equipment for intermediate purification steps.
The ability to make and share complex azaindole-based compounds supports a growing trend: open-access chemical toolboxes available to academic and industrial researchers worldwide. From what I’ve seen, building off an intermediate like 4-Bromo-3-Iodo-7-Azaindole means chemists can submit complete synthetic procedures to public repositories, making newly created compounds more traceable and accessible for future projects. This push toward transparency, paired with rigorous analytical characterization, strengthens trust and reproducibility in the wider scientific community.
It’s no surprise that major chemical suppliers and open research platforms now offer this building block alongside analysis data—NMR, HRMS, melting point, and so forth—so every buyer can independently check quality before putting their own resources behind a project. Modern synthetic innovation depends on that kind of reliability, which I learned early in my career the hard way, after the headaches that came from sketchy, poorly documented starting materials.
Looking back on the bottlenecks I faced working in both academic and contract synthesis labs, availability of specialized heterocyclic intermediates often slowed or limited research directions. Historically, niche compounds like 4-Bromo-3-Iodo-7-Azaindole suffered either from limited supply or high cost, as few suppliers tackled the challenges of halide-selective functionalization and quality control. As global demand for novel azaindole scaffolds grew, economies of scale improved, and so did process chemistry techniques. More researchers in more places can now access larger batches for lead optimization or pilot studies without breaking the bank or risking unknown impurities.
One challenge remains: making sure that as demand grows, scale-up methods keep pace with environmental and safety standards. Chemists developing greener halogenation reactions or solvent recycling practices hold enormous sway in this area. Sharing those advances not only matters for sustainability, but also for helping labs everywhere maintain high standards without sacrificing innovation.
If there’s something I would wish for every up-and-coming medicinal or materials chemist, it would be access to reliable, flexible building blocks that keep options open while still respecting budgets and workflow constraints. From recent publications and conversations across the lab bench, it’s clear that 4-Bromo-3-Iodo-7-Azaindole hits a sweet spot for utility and adaptability—offering site-selectivity, rich chemical handles, and a well-studied core that new students can confidently build on. Those advantages ripple across discovery, from quick-hit analog synthesis to deep diversification campaigns where every saved step compounds into more data, more insight, and fewer late-stage surprises.
I’ve seen research teams leap ahead after trading in clunky, single-handle intermediates for this dual-halide approach. The difference shows up in published patent claims and the speed at which a “maybe” becomes a tangible new molecule. That’s not just a win for individual labs but for the broader pursuit of better medicines, smarter materials, and more creative science—built on foundations that handle real-life needs, not just theoretical ideals.
A core principle in chemistry, shaped by years of progress and hard lessons, revolves around integrity and stewardship. Making useful compounds is only part of the story. Ensuring their safe handling, transparent documentation, and responsible sourcing ties just as tightly to long-term success. As I reflect on my past projects using halogenated azaindoles, I see a welcome shift: researchers increasingly value supply chain traceability, environmental footprint, and crystal-clear sharing of analytical data. Products like 4-Bromo-3-Iodo-7-Azaindole, offered with thorough documentation, push this cultural change forward.
Modern labs, whether in academia or industry, have fostered new expectations. Project managers and funding bodies look for thorough project records and sustainable sourcing. Rising generations of chemists expect both synthetic power and responsible stewardship in their tools. This transition promises lasting improvements—a culture where flexible molecular building blocks come paired with a deeper recognition of their impact on bench work and on the world beyond.
From small-scale screening to broader lead expansion, using 4-Bromo-3-Iodo-7-Azaindole frees synthetic teams to devote energy where it really counts. Streamlining synthesis from step one cuts overall costs, shortens project timelines, and reduces avoidable waste. Training students with adaptable molecules breeds skill and resilience—there’s less reliance on obscure protocols and more room for inventiveness. And as global challenges mount, the scientific community builds resilience by sharing better routes, greener processes, and lessons learned from both success and struggle.
If there’s anything chemistry has taught me, it’s that the right starting point can change the arc of discovery. Each time I work with or recommend 4-Bromo-3-Iodo-7-Azaindole, I think about all the next-generation medicines and materials that could spring from such a scaffold—supported not just by innovation in the flask, but also by the collaborative, careful spirit that drives science ahead. For chemists looking to keep pace with new ideas, this is one intermediate worth knowing well.